Pi3kδ expression is increased in peripheral lung macrophages in COPD patients Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017
Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
The comparison of subsets of blood lymphocytes in patients with lung cancer,COPD,and tuberculosis according to healthy controls Source: Eur Respir J 2001; 18: Suppl. 33, 76s Year: 2001
BALF immune profile - towards clinical usefulness in lung cancer. Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer Year: 2019
Pleural and systemic cytokine expression profiles in patients with lung cancer Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018
DNA damage in lymphocytes from COPD patients with and without lung cancer Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017
The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005
Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017
Comparison of induced and spontaneous sputum in the diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 64s Year: 2001
Alterations of serum inflammatory biomarkers in the healthy and lung cancer patients before and post chemotherapy Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
The expression and clinical significance of PD-L1+ CD68+ macrophages in peripheral blood mononuclear cells of non-small cell lung cancer Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
Expression of MAGE in the induced sputum of lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 595s Year: 2002
Sputum protein profiles for monitoring lung pathophysiology in chronic lung diseases Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012
How to evaluate the immune status of lung cancer patients before immunotherapy Source: Breathe, 13 (4) 291; 10.1183/20734735.001917 Year: 2017
Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003
How to define the immune status of lung cancer patient Source: International Congress 2015 – Stop immune tolerance in lung cancer! Year: 2015
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy Source: Eur Respir J, 59 (3) 2101798; 10.1183/13993003.01798-2021 Year: 2022
Studies on blood lymphocytes apoptosis in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004